Skip to main content

Table 1 Association between Covid-19 status and outcomes

From: Demographic and clinical characteristics of severe Covid-19 infections: a cross-sectional study from Mashhad University of Medical Sciences, Iran

Variable investigated Outcome
Number (%)
P-value
Deceased
(n = 353)
Recovered
(n = 925)
Continuous age - mean (SD) 67.1 (15.9) 53.0 (18.3) 0.0001c
Age (categorical) 0–9 1 (0.3) 12 (1.3) 0.0001d
10–19 1 (0.3) 12 (1.3)
20–29 4 (1.1) 66 (7.1)
30–39 15 (4.2) 130 (14.1)
40–49 25 (7.1) 170 (18.4)
50–59 47 (13.3) 193 (20.9)
60–69 104 (29.5) 165 (17.8)
70–79 74 (21.0) 102 (11.0)
80–89 62 (17.6) 67 (7.2)
90–99 19 (5.4) 8 (0.9)
100–109 1 (0.3) 0 (0.0)
Sex Female 129 (36.5) 356 (38.5) 0.52d
Male 224 (63.5) 569 (61.5)
Therapeutic approach Antiviral & antibiotic 149 (42.2) 401 (43.4) 0.08d
Conservative 71 (20.1) 139 (15.0)
Antiviral 133 (37.7) 385 (41.6)
Specific medication used Lopinavir/ritonavir and antibiotica 131 (37.1) 120 (13.0) 0.001d
Oseltamivirb 222 (62.9) 805 (87.0)
Body temperature (C°) - mean (SD) 37.6 (0.76) 37.7 (0.73) 0.09c
Hospitalization (days) - median (IQR) 9.0 (6.0–14.0) 9.0 (6.0–14.0) 0.18c
  1. aprescribed for severe cases; bprescribed for mild cases; cMann–Whitney U test was used; dChi-square test was used